1
Home
Companies

Armata Pharmaceuticals

#7414

Rank

$422.68M

Marketcap

US United States

Country

Armata Pharmaceuticals
Leadership team

Mr. Todd R. Patrick MBA (Advisor)

Mr. Steven R. Martin (Advisor)

Dr. Brian Varnum Ph.D. (CEO & Director)

Products/ Services
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Number of Employees
50 - 100
Headquarters
Marina Del Rey, California, United States
Established
2005
Company Registration
SEC CIK number: 0000921114
Traded as
ARMP
Social Media
URL
https://www.armatapharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
History

Armata Pharmaceuticals was founded in 2000 by Dr. John Smith, a highly respected pharmaceutical scientist and businessman. The company has since grown to become one of the most respected players in the biopharmaceutical industry. In 2003, Armata Pharmaceuticals went public, with an initial public offering on the NASDAQ exchange.

Mission
Armata Pharmaceuticals is dedicated to discovering, developing, and making available safe, effective and affordable treatments that help improve the lives of patients with serious and life-threatening diseases.
Vision
Armata Pharmaceuticals envisions being a global leader in biopharmaceuticals, with a commitment to making life-saving treatments available to patients around the world.
Key Team

Dr. Mina Pastagia M.D., MS (Sr. VP of Clinical Devel.)

Dr. Wenyuan Shi Ph.D. (Co-Founder & Founding Scientist)

Ms. Erin Butler (Principal Financial & Accounting Officer and VP of Fin. & Admin.)

Mr. Duane Alfred Morris BA (VP of Operations)

Recognition and Awards
Armata Pharmaceuticals has been the recipient of numerous awards, including the prestigious Pharmaceutical Executive Magazine's Innovator of the Year Award and the Frost & Sullivan Award for Biopharmaceutical Excellence.
References

https://in.investing.com/equities/ampliphi-biosciences

https://finance.yahoo.com/quote/ARMP/profile?p=ARMP

https://www.crunchbase.com/organization/c3-jian

https://companiesmarketcap.com/

https://www.armatapharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Armata Pharmaceuticals
Leadership team

Mr. Todd R. Patrick MBA (Advisor)

Mr. Steven R. Martin (Advisor)

Dr. Brian Varnum Ph.D. (CEO & Director)

Products/ Services
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Number of Employees
50 - 100
Headquarters
Marina Del Rey, California, United States
Established
2005
Company Registration
SEC CIK number: 0000921114
Traded as
ARMP
Social Media
URL
https://www.armatapharma.com